Go Pro

Matthew Harrison Analyst Performance

Analyst at Susquehanna

Matthew Harrison is a stock analyst at Susquehanna focused in the healthcare sector, covering 41 publicly traded companies. Over the past year, Matthew Harrison has issued 56 stock ratings, including buy, hold, and sell recommendations. While full access to Matthew Harrison's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Matthew Harrison's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
243 Last 12 Years
Buy Recommendations
50.21% 117 Buy Ratings
Companies Covered
41 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy50.2%117 ratings
Hold44.6%104 ratings
Sell5.2%12 ratings

Out of 233 total stock ratings issued by Matthew Harrison at Susquehanna, the majority (50.2%) have been Buy recommendations, followed by 44.6% Hold and 5.2% Sell.

Exchange Coverage

ExchangePercentageCount
NASDAQ
78.0% of companies on NASDAQ
32 companies
NYSE
22.0% of companies on NYSE
9 companies

Matthew Harrison, an analyst at Susquehanna, currently covers 41 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Healthcare
39 companies
95.1%
Industrials
1 company
2.4%
Communication Services
1 company
2.4%

Matthew Harrison of Susquehanna specializes in stock coverage within the Healthcare sector, with additional focus on Industrials and Communication Services companies.

Coverage Industries

IndustryPercentage
BIOTECHNOLOGY
31 companies
75.6%
PHARMACEUTICALS
8 companies
19.5%
GROUND TRANSPORTATION
1 company
2.4%
MEDIA
1 company
2.4%

Matthew Harrison's Ratings History at Susquehanna

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Legend Biotech Corporation Sponsored ADR stock logo
LEGN
Legend Biotech
9/4/2026Set Price Target$21.75$65.00
Moderna, Inc. stock logo
MRNA
Moderna
8/19/2026Reiterated Rating$174.38Neutral
Atea Pharmaceuticals, Inc. stock logo
AVIR
Atea Pharmaceuticals
8/13/2026Boost Price Target$5.37$7.00Equal Weight
Legend Biotech Corporation Sponsored ADR stock logo
LEGN
Legend Biotech
8/12/2026Boost Price Target$21.46$49.00Overweight
Insmed, Inc. stock logo
INSM
Insmed
8/7/2026Reiterated Rating$129.81$218.00Overweight
BioMarin Pharmaceutical Inc. stock logo
BMRN
BioMarin Pharmaceutical
8/7/2026Boost Price Target$63.04$124.00Overweight
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
7/31/2026Boost Price Target$753.48$758.00Equal Weight
Biogen Inc. stock logo
BIIB
Biogen
7/30/2026Boost Price Target$207.07$231.00Equal Weight
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
7/27/2026Lower Price Target$131.59$165.00Overweight
Ryder System, Inc. stock logo
R
Ryder System
7/24/2026Boost Price Target$265.16$310.00Positive
Denali Therapeutics Inc. stock logo
DNLI
Denali Therapeutics
7/23/2026Boost Price Target$22.91$36.00Overweight
Moderna, Inc. stock logo
MRNA
Moderna
7/8/2026Boost Price Target$76.32$39.00Equal Weight
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
7/8/2026Lower Price Target$664.62$730.00Equal Weight
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
7/8/2026Lower Price Target$135.63$166.00Overweight
Pharvaris N.V. stock logo
PHVS
Pharvaris
6/25/2026Boost Price Target$33.29$46.00Overweight
argenex SE stock logo
ARGX
argenex
6/24/2026Boost Price Target$853.40$1,180.00Overweight
Biogen Inc. stock logo
BIIB
Biogen
6/18/2026Boost Price Target$198.67$224.00Equal Weight
Denali Therapeutics Inc. stock logo
DNLI
Denali Therapeutics
5/22/2026Lower Price Target$18.64$35.00Overweight
Denali Therapeutics Inc. stock logo
DNLI
Denali Therapeutics
5/14/2026Lower Price Target$19.28$40.00Overweight
Legend Biotech Corporation Sponsored ADR stock logo
LEGN
Legend Biotech
5/13/2026Lower Price Target$28.27$48.00Overweight
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
5/8/2026Lower Price Target$131.33$168.00
BioMarin Pharmaceutical Inc. stock logo
BMRN
BioMarin Pharmaceutical
5/5/2026Lower Price Target$54.01$119.00Overweight
Biogen Inc. stock logo
BIIB
Biogen
4/30/2026Boost Price Target$187.53$206.00Equal Weight
Biogen Inc. stock logo
BIIB
Biogen
4/28/2026Boost Price Target$183.30$200.00Equal Weight
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
4/28/2026Boost Price Target$129.38$175.00Overweight
Biogen Inc. stock logo
BIIB
Biogen
4/10/2026Boost Price Target$173.98$200.00Equal Weight
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
4/10/2026Boost Price Target$140.63$175.00Overweight
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
4/10/2026Boost Price Target$746.69$796.00Equal Weight
Insmed, Inc. stock logo
INSM
Insmed
3/30/2026Upgrade$145.30$212.00Overweight
Denali Therapeutics Inc. stock logo
DNLI
Denali Therapeutics
3/26/2026Boost Price Target$20.16$42.00Overweight
Legend Biotech Corporation Sponsored ADR stock logo
LEGN
Legend Biotech
3/11/2026Lower Price Target$20.13$49.00Overweight
Insmed, Inc. stock logo
INSM
Insmed
2/20/2026Set Price Target$165.38$166.00
Moderna, Inc. stock logo
MRNA
Moderna
2/16/2026Set Price Target$42.23$30.00
Ryder System, Inc. stock logo
R
Ryder System
2/13/2026Boost Price Target$208.01$250.00Positive
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
2/11/2026Boost Price Target$147.23$171.00Overweight
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
2/2/2026Boost Price Target$754.63$769.00Equal Weight
Insmed, Inc. stock logo
INSM
Insmed
1/30/2026Boost Price Target$156.73$162.00Equal Weight
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
1/13/2026Lower Price Target$122.43$150.00Overweight
Denali Therapeutics Inc. stock logo
DNLI
Denali Therapeutics
1/8/2026Reiterated Rating$16.95$40.00Overweight
IO Biotech, Inc. stock logo
IOBT
IO Biotech
1/8/2026Downgrade$0.63Underweight
Ready to give options a try? Your first trade (Ticker included) -INSIDE (Ad)

Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and stinging losses? Dave Aquino is giving away the exact 11-hour options strategy he uses in volatile markets. You get the plain English blueprint behind the strategy and the very same "rinse and repeat" ticker he's traded nearly 900 times with a 95.3% success rate. It's so simple to understand, you could trade it tomorrow.tc pixel

Moderna, Inc. stock logo
MRNA
Moderna
12/12/2025Lower Price Target$29.91$28.00Equal Weight
Legend Biotech Corporation Sponsored ADR stock logo
LEGN
Legend Biotech
12/12/2025Lower Price Target$22.63$50.00Overweight
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
12/12/2025Boost Price Target$737.42$768.00Equal Weight
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
12/12/2025Boost Price Target$123.21$151.00Overweight
Pharvaris N.V. stock logo
PHVS
Pharvaris
12/4/2025Boost Price Target$29.36$41.00Overweight
argenex SE stock logo
ARGX
argenex
12/4/2025Boost Price Target$922.82$1,110.00Overweight
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
12/3/2025Downgrade$742.00$767.00Equal Weight
Pharvaris N.V. stock logo
PHVS
Pharvaris
11/14/2025Boost Price Target$24.47$37.00Overweight
Zentalis Pharmaceuticals, Inc. stock logo
ZNTL
Zentalis Pharmaceuticals
11/12/2025Lower Price Target$1.34$4.00Equal Weight
BioMarin Pharmaceutical Inc. stock logo
BMRN
BioMarin Pharmaceutical
10/28/2025Lower Price Target$52.67$98.00Overweight
Biogen Inc. stock logo
BIIB
Biogen
10/10/2025Boost Price Target$147.72$149.00Equal Weight
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
10/10/2025Lower Price Target$412.64$438.00Equal Weight
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
10/10/2025Lower Price Target$567.36$756.00Overweight
Moderna, Inc. stock logo
MRNA
Moderna
10/10/2025Boost Price Target$26.62$32.00Equal Weight
argenex SE stock logo
ARGX
argenex
10/1/2025Boost Price Target$780.96$1,040.00Overweight
IO Biotech, Inc. stock logo
IOBT
IO Biotech
9/30/2025Downgrade$0.37Equal Weight
Denali Therapeutics Inc. stock logo
DNLI
Denali Therapeutics
8/18/2025Lower Price Target$14.81$30.00Overweight
Insmed, Inc. stock logo
INSM
Insmed
8/13/2025Reiterated Rating$122.00$126.00Equal Weight
Legend Biotech Corporation Sponsored ADR stock logo
LEGN
Legend Biotech
8/12/2025Boost Price Target$36.24$83.00Overweight
IO Biotech, Inc. stock logo
IOBT
IO Biotech
8/12/2025Lower Price Target$1.05$4.00Overweight
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
8/5/2025Set Price Target$472.27$439.00Equal Weight
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
8/1/2025Reiterated Rating$545.46$761.00Overweight
Moderna, Inc. stock logo
MRNA
Moderna
8/1/2025Reiterated Rating$29.56$32.00Equal Weight
Biogen Inc. stock logo
BIIB
Biogen
8/1/2025Lower Price Target$124.95$144.00Equal Weight
argenex SE stock logo
ARGX
argenex
8/1/2025Boost Price Target$667.75$766.00Overweight
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
7/29/2025Boost Price Target$13.86$20.00Equal Weight
BioMarin Pharmaceutical Inc. stock logo
BMRN
BioMarin Pharmaceutical
7/22/2025Lower Price Target$58.00$96.00Overweight
Insmed, Inc. stock logo
INSM
Insmed
7/17/2025Boost Price Target$104.59$108.00Overweight
Ryder System, Inc. stock logo
R
Ryder System
7/15/2025Initiated Coverage$175.19$215.00Positive
Legend Biotech Corporation Sponsored ADR stock logo
LEGN
Legend Biotech
7/10/2025Reiterated Rating$39.16$81.00Overweight
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
7/10/2025Lower Price Target$561.21$754.00Overweight
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
6/20/2025Lower Price Target$438.85$460.00Equal Weight
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
6/16/2025Reiterated Rating$20.30$40.00Equal Weight
Insmed, Inc. stock logo
INSM
Insmed
6/11/2025Boost Price Target$94.94$102.00Overweight
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
6/2/2025Lower Price Target$493.24$755.00Overweight
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
5/7/2025Lower Price Target$46.75$113.00Overweight
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
5/6/2025Boost Price Target$436.06$464.00Equal Weight
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
4/25/2025Boost Price Target$103.65$135.00Overweight
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
4/11/2025Lower Price Target$49.41$182.00Overweight
Atea Pharmaceuticals, Inc. stock logo
AVIR
Atea Pharmaceuticals
4/11/2025Lower Price Target$2.65$6.00Equal Weight
Biogen Inc. stock logo
BIIB
Biogen
4/9/2025Lower Price Target$111.00$152.00Equal Weight
Moderna, Inc. stock logo
MRNA
Moderna
4/9/2025Lower Price Target$24.62$32.00Equal Weight
Legend Biotech Corporation Sponsored ADR stock logo
LEGN
Legend Biotech
3/17/2025Lower Price Target$38.25$80.00Overweight
Tenaya Therapeutics, Inc. stock logo
TNYA
Tenaya Therapeutics
3/12/2025Lower Price Target$0.54$5.00Overweight
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
3/11/2025Boost Price Target$117.21$130.00Overweight
Denali Therapeutics Inc. stock logo
DNLI
Denali Therapeutics
3/7/2025Initiated Coverage$16.47$33.00Overweight
Biogen Inc. stock logo
BIIB
Biogen
2/13/2025Lower Price Target$136.88$157.00Equal Weight
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
2/12/2025Boost Price Target$96.14$123.00Overweight
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
2/11/2025Boost Price Target$469.97$459.00Equal Weight
Insmed, Inc. stock logo
INSM
Insmed
2/6/2025Boost Price Target$81.44$90.00Overweight
The end may be near for these iconic stocks (Ad)

Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are triggering a historic wealth transfer already underway in 2026. Household names like Intuit (-57%), Boston Scientific (-49%), and Tractor Supply (-40%) are cratering, while lesser-known companies like Sandisk (+573%) and Rackspace (+444%) surge. Chaikin has identified specific stocks he believes investors should sell before they fall further - and the names may surprise you. He's also pinpointing a company tapped as Nvidia's self-driving partner and a potential AI megadeal that could split into three high-growth stocks. Stream his free presentation to get every buy and sell recommendation with no membership or credit card required.tc pixel

Watch Marc Chaikin's free presentation and get his full buy-and-sell list today
Comcast Corporation stock logo
CMCSA
Comcast
1/31/2025Lower Price Target$33.77$55.00Buy
Moderna, Inc. stock logo
MRNA
Moderna
1/15/2025Lower Price Target$35.00$38.00Equal Weight